URGN Operating Cash Flow
Urogen Pharma Ltd · Operating Cash Flow
URGN Operating Cash Flow
Latest reported-$158.92Mperiod ending
URGN TTM Operating Cash Flow ($4.19M → -$158.92M)
TTM operating cash flow
High-resolution chart · PNG
URGN operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -158,917,000 | |
| -165,736,000 | |
| -162,444,000 | |
| -137,738,000 | |
| -123,132,000 | |
| -107,055,000 | |
| -96,766,000 | |
| -96,202,964 | |
| -85,837,964 | |
| -82,363,964 | |
| -76,435,964 | |
| -85,132,000 | |
| -84,533,036 | |
| -88,458,036 | |
| -86,647,036 | |
| -84,965,036 | |
| -86,741,000 | |
| -81,487,000 | |
| -84,892,000 | |
| -86,064,000 | |
| -92,668,000 | |
| -97,652,000 | |
| -105,886,000 | |
| -110,644,000 | |
| -98,092,000 | |
| -88,718,000 | |
| -71,017,000 | |
| -55,301,000 | |
| -52,052,000 | |
| -45,644,000 | |
| -37,334,000 | |
| -33,012,000 | |
| -21,136,000 | |
| -16,450,000 | |
| -9,571,000 | |
| 9,737,000 | |
| 3,614,000 | |
| 4,075,000 | |
| 4,189,000 | |
| -10,676,000 | |
| -8,481,000 | |
| -6,757,000 |